Efflux pumps of Gram-negative bacteria: What they do, how they do it, with what and how to deal with them

Frontiers in Pharmacology

Volumn 4 JAN, Issue , 2014, Pages

  Amaral, Leonard ^a,b   Martins, Ana ^a,b   Spengler, Gabriella ^b   Molnar, Joseph ^b  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Biofilms; Efflux pumps; Genetic responses to antibiotic exposure; Gram negative bacteria; Inhibition; Inhibitory agents of efflux pumps and QS; Methods for identification of bacteria that over express efflux pumps; Quorum sensing

Indexed keywords

ACREF TOLC EFFLUX PUMP; AGAR; CARRIER PROTEINS AND BINDING PROTEINS; EFFLUX PUMP; ETHIDIUM BROMIDE; PHENOTHIAZINE DERIVATIVE; PORIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ACRAB GENE; ANTIBIOTIC RESISTANCE; AUTOANALYSIS; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL MUTATION; BACTERIUM IDENTIFICATION; BIOFILM; DOWN REGULATION; GENE ACTIVITY; GENE EXPRESSION; GENETIC REGULATION; GRAM NEGATIVE BACTERIUM; GROWTH INHIBITION; HUMAN; MARA GENE; MARB GENE; MARR GENE; MICF GENE; NONHUMAN; OMPF GENE; QUORUM SENSING; REGULON; REVIEW; ROB GENE; SOXS GENE; STRESS; UPREGULATION;

EID: 84893783941     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00168     Document Type: Review

References (109)

1. Abbate, E., Vescovo, M., Natiello, M., Cufré, M., García, A., Gonzalez Montaner, P., et al. (2012). Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine. J. Antimicrob. Chemother. 67, 473-477. doi: 10.1093/jac/dkr500.
2. Achouak, W., Heulin, T., and Pagès, J. M. (2001). Multiple facets of bacterial porins. FEMS Microbiol. Lett. 199, 1-7. doi: 10.1111/j.1574-6968.2001.tb10642.x.
3. Amaral, L., Boeree, M. J., Gillespie, S. H., Udwadia, Z. F., and van Soolingen, D. (2010a). Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! Int. J. Antimicrob. Agents 35, 524-526. doi: 10.1016/j.ijantimicag.2009.12.019.
4. Amaral, L., Martins, A., Molnar, J., Kristiansen, J. E., Martins, M., Viveiros, M., et al. (2010b). Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB. In Vivo 24, 409-424.
5. Amaral, L., Cerca, P., Spengler, G., Machado, L., Martins, A., Couto, I., et al. (2011a). Ethidium bromide efflux by Salmonella: modulation by metabolic energy, pH, ions and phenothiazines. Int. J. Antimicrob. Agents 38, 140-145. doi: 10.1016/j.ijantimicag.2011.03.014.
6. Amaral, L., Fanning, S., and Pagès, J. M. (2011b). Efflux pumps of Gram-negative bacteria: genetic responses to stress and the modulation of their activity by pH, inhibitors, and phenothiazines. Adv. Enzymol. Relat. Areas Mol. Biol. 77, 61-108.
7. Amaral, L., Kristiansen, J., and Lorian, V. (1992). Synergic effect of chlorpromazine on the activity of some antibiotics. J. Antimicrob. Chemother. 30, 556-558. doi: 10.1093/jac/30.4.556.
8. Amaral, L., and Kristiansen, J. E. (2000). Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies. Int. J. Antimicrob. Agents 14, 173-176. doi: 10.1016/S0924-8579(99)00153-3.
9. Amaral, L., Kristiansen, J. E., Abebe, L. S., and Millett, W. (1996). Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. J. Antimicrob. Chemother. 38, 1049-1053. doi: 10.1093/jac/38.6.1049.
10. Amaral, L., Kristiansen, J. E., Frolund Thomsen, V., and Markovich, B. (2000). The effects of chlorpromazine on the outer cell wall of Salmonella typhimurium in ensuring resistance to the drug. Int. J. Antimicrob. Agents 14, 225-229. doi: 10.1016/S0924-8579(00)00136-9.
11. Amaral, L., and Lorian, V. (1991). Effects of chlorpromazine on the cell envelope proteins of Escherichia coli. Antimicrob. Agents Chemother. 35, 1923-1924. doi: 10.1128/AAC.35.9.1923.
12. Amaral, L., Martins, M., and Viveiros, M. (2007). Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J. Antimicrob. Chemother. 59, 1237-1246. doi: 10.1093/jac/dkl500.
13. Amaral, L., and Molnar, J. (2012). Inhibitors of efflux pumps of Gram-negative bacteria inhibit quorum sensing. Open J. Pharmacol. 2, 2.
14. Amaral, L., Spengler, G., Viveiros, M., Rodrigues, L., Martins, A., Couto, I., et al. (2008). Assessment and comparison of efflux pumps of cancer cells and MDR bacteria under physiological conditions by a real-time semi-automated method. Anticancer Res. 28, 3193-3194.
15. Amaral, L., Udwadia, Z., Abbate, E., and van Soolingen, D. (2012). The added effect of thioridazine in the treatment of drug-resistant tuberculosis. Int. J. Tuberc. Lung Dis. 16, 1706-1708. doi: 10.5588/ijtld.12.0616.
16. Amaral, L., and Viveiros, M. (2012). Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections. Int. J. Antimicrob. Agents 39, 376-380. doi: 10.1016/j.ijantimicag.2012.01.012.
17. Amaral, L., Viveiros, M., and Molnar, J. (2004). Antimicrobial activity of phenothiazines. In Vivo 18, 725-731.
18. Ariza, R. R., Li, Z., Ringstad, N., and Demple, B. (1995). Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. J. Bacteriol. 177, 1655-1661.
19. Basle, A., Rummel, G., Storici, P., Rosenbusch, J. P., and Schirmer, T. (2006). Crystal structure of osmoporin OmpC from E. coli at 2.0 A. J. Mol. Biol. 362, 933-942. doi: 10.1016/j.jmb.2006.08.002.
20. Bhattacharjee, H., Zhou, T., Li, J., Gatti, D. L., Walmsley, A. R., and Rosen, B. P. (2000). Structure-function relationships in an anion-translocating ATPase. Biochem. Soc. Trans. 28, 520-526. doi: 10.1042/0300-5127:0280520.
21. Bohnert, J. A., Schuster, S., Fahnrich, E., Trittler, R., and Kern, W. V. (2007). Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF). J. Antimicrob. Chemother. 59, 1216-1222. doi: 10.1093/jac/dkl426.
22. Castillo-Keller, M., Vuong, P., and Misra, R. (2006). Novel mechanism of Escherichia coli porin regulation. J. Bacteriol. 188, 576-586. doi: 10.1128/JB.188.2.576-586.2006.
23. Cerca, P., Martins, A., Couto, I., Viveiros, M., and Amaral, L. (2011). Competition between substrates of the efflux pump system of Salmonella enteritidis. In Vivo 25, 597-602.
24. Chen, S., Zhang, A., Blyn, L. B., and Storz, G. (2004). MicC, a second small-RNA regulator of Omp protein expression in Escherichia coli. J. Bacteriol. 186, 6689-6697. doi: 10.1128/JB.186.20.6689-6697.2004.
25. Costa, S. S., Ntokou, E., Martins, A., Viveiros, M., Pouranas, S., Couto I., et al. (2010). Identification of the plasmid encoded qacA efflux pump gene in the methicillin-resistant Staphylococcus aureus (MRSA) strain HPV107, a representative of the MRSA Iberian clone. Int. J. Antimicrob. Agents 36, 557-561. doi: 10.1016/j.ijantimicag.2010.08.006.
26. Couto, I., Costa, S. S., Viveiros, M., Martins, M., and Amaral, L. (2008). Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide. J. Antimicrob. Chemother. 62, 504-513. doi: 10.1093/jac/dkn217.
27. Cowan, S. W., Schirmer, T., Rummel, G., Steiert, M., Ghosh, R., Pauptit, R. A., et al. (1992). Crystal structures explain functional properties of two E. coli porins. Nature 358, 727-733. doi: 10.1038/358727a0.
28. Crémieux, A., Chevalier, J., Sharples, D., Berny, H., Galy, A. M., Brouant P., et al. (1995). Antimicrobial activity of 9-oxo and 9-thio acridines: correlation with intercalation into DNA and effects on macromolecular biosynthesis. Res. Microbiol. 146, 73-83. doi: 10.1016/0923-2508(96)80272-5.
29. Daniel, W. A., and Wójcikowski, J. (1999a). Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants. Eur. Neuropsychopharmacol. 9, 483-491. doi: 10.1016/S0924-977X(99)00034-6.
30. Daniel, W. A., and Wójcikowski, J. (1999b). The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions. Toxicol. Appl. Pharmacol. 158, 115-124. doi: 10.1006/taap.1999.8688.
31. Dasgupta, A., Mukherjee, S., Chaki, S., Dastidar, S. G., Hendricks, O., Christensen, J. B., et al. (2010). Thioridazine protects the mouse from a virulent infection by Salmonella enterica serovar Typhimurium 74. Int. J. Antimicrob. Agents 35, 174-176. doi: 10.1016/j.ijantimicag.2009.09.027.
32. Davin-Regli, A., and Pagès, J. M. (2006). "Regulation of efflux pumps in Enterobacteriaceae: genetic and chemical effectors," in Antimicrobial Resistance in Bacteria, ed. C. F. Zmabiles-Cuevos (Norfolk: Horizon Biosciences), 55-75.
33. Delihas, N., and Forst, S. (2001). MicF: an antisense RNA gene involved in response of Escherichia coli to global stress factors. J. Mol. Biol. 313, 1-12. doi: 10.1006/jmbi.2001.5029.
34. Dupont, M., De, E., Chollet, R., Chevalier, J., and Pagès, J. M. (2004). Enterobacter aerogenes OmpX, a cation-selective channel mar-and osmo-regulated. FEBS Lett. 569, 27-30. doi: 10.1016/j.febslet.2004.05.047.
35. Dutta, N. K., Mazumdar, K., Dastidar, S. G., Karakousis, P. C., and Amaral, L. (2011). New patentable use of an old neuroleptic compound thioridazine to combat tuberculosis: a gene regulation perspective. Recent Pat. Antiinfect. Drug Discov. 6, 128-138. doi: 10.2174/157489111796064597.
36. Dutta, N. K., Mehra, S., and Kaushal, D. (2010). A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine. PLoS ONE 5:e10069. doi: 10.1371/journal.pone.0010069.
37. Dymek, A., Armada, A., Handzlik, J., Viveiros, M., Spengler, G., Molnar, J., et al. (2012). The activity of 16 new hydantoin compounds on the intrinsic and overexpressed efflux pump system of Staphylococcus aureus. In Vivo 26, 223-229.
38. Eicher, T., Cha, H. J., Seeger, M. A., Brandstätter, L., El-Delik, J., Bohnert, J. A., et al. (2012). Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc. Natl. Acad. Sci. U.S.A. 109, 5687-5692. doi: 10.1073/pnas.1114944109.
39. Feniouk, B. A., and Junge, W. (2005). Regulation of the F0F1-ATP synthase: the conformation of subunit epsilon might be determined by directionality of subunit gamma rotation. FEBS Lett. 579, 5114-5118. doi: 10.1016/j.febslet.2005.08.030.
40. Ferenci, T. (2005). Maintaining a healthy SPANC balance through regulatory and mutational adaptation. Mol. Microbiol. 57, 1-8. doi: 10.1111/j.1365-2958.2005.04649.x.
41. Gootz, T. D. (2006). The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance. Biochem. Pharmacol. 71, 1073-1084. doi: 10.1016/j.bcp.2005.11.006.
42. Guillier, M., Gottesman, S., and Storz, G. (2006). Modulating the outer membrane with small RNAs. Genes Dev. 20, 2338-2348. doi: 10.1101/gad.1457506.
43. Gunn, J. S. (2008). The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol. 16, 284-290. doi: 10.1016/j.tim.2008.03.007.
44. Hall, M. N., and Silhavy, T. J. (1981). The ompB locus and the regulation of the major outer membrane porin proteins of Escherichia coli K12. J. Mol. Biol. 146, 23-43. doi: 10.1016/0022-2836(81)90364-8.
45. Kornblum, J., Hartman, B. J., Novick, R. P., and Tomasz, A. (1986). Conversion of a homogeneously methicillin-resistant strain of Staphylococcus aureus to heterogeneous resistance by Tn551-mediated insertional inactivation. Eur. J. Clin. Microbiol. 5, 714-718. doi: 10.1007/BF02013311.
46. Kristiansen, J. E., and Amaral, L. (1997). The potential management of resistant infections with non-antibiotics. J. Antimicrob. Chemother. 40, 319-327. doi: 10.1093/jac/40.3.319.
47. Kristiansen, M. M., Leandro, C., Ordway, D., Martins, M., Viveiros, M., Pacheco, T., et al. (2003). Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro. Int. J. Antimicrob. Agents 22, 250-253. doi: 10.1016/S0924-8579(03)00200-0.
48. Kristiansen, M. M., Leandro, C., Ordway, D., Martins, M., Viveiros, M., Pacheco, T., et al. (2006). Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump. In Vivo 20, 361-366.
49. Lewis, K. (2001). In search of natural substrates and inhibitors of MDR pumps. J. Mol. Microbiol. Biotechnol. 3, 247-254.
50. Li, X. Z., and Nikaido, H. (2009). Efflux-mediated drug resistance in bacteria: an update. Drugs 69, 1555-1623. doi: 10.2165/11317030-000000000-00000.
51. Liu, X., and Ferenci, T. (2001). An analysis of multifactorial influences on the transcriptional control of ompF and ompC porin expression under nutrient limitation. Microbiology 147, 2981-2989.
52. Lorca, G. L., Barabote, R. D., Zlotopolski, V., Tran, C., Winnen, B., Hvorup, R. N., et al. (2007). Transport capabilities of eleven Gram-positive bacteria: comparative genomic analyses. Biochim. Biophys. Acta 1768, 1342-1366. doi: 10.1016/j.bbamem.2007.02.007.
53. Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H., and Hearst, J. E. (1995). Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16, 45-55. doi: 10.1111/j.1365-2958.1995.tb02390.x.
54. Ma, D., Cook, D. N., Hearst, J. E., and Nikaido, H. (1994). Efflux pumps and drug resistance in Gram-negative bacteria. Trends Microbiol. 2, 489-493. doi: 10.1016/0966-842X(94)90654-8.
55. Machado, D., Couto, I., Perdigão, J., Rodrigues, L., Portugal, I., Baptista, P., et al. (2012). Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. PLoS ONE 7:e34538. doi: 10.1371/journal.pone.0034538.
56. Machado, L., Spengler, G., Evaristo, M., Handzlik, J., Molnár, J., Viveiros, M., et al. (2011). Biological activity of twenty-three hydantoin derivatives on intrinsic efflux pump system of Salmonella enterica serovar Enteritidis NCTC 13349. In Vivo 25, 769-772.
57. Marshall, N. J., and Piddock, L. J. (1997). Antibacterial efflux systems. Microbiologia 13, 285-300.
58. Martins, A., and Amaral, L. (2012). Screening for efflux pump systems of bacteria by the new acridine orange agar method. In Vivo 26, 203-206.
59. Martins, A., Couto, I., Aagaard, L., Martins, M., Viveiros, M., Kristiansen, J. E., et al. (2007). Prolonged exposure of methicillin-resistant Staphylococcus aureus (MRSA) COL strain to increasing concentrations of oxacillin results in a multidrug-resistant phenotype. Int. J. Antimicrob. Agents 29, 302-305. doi: 10.1016/j.ijantimicag.2006.10.012.
60. Martins, A., Hunyadi, A., and Amaral, L. (2013a). Mechanisms of resistance in bacteria: an evolutionary approach. Open Microbiol. J. 7, 53-58. doi: 10.2174/1874285801307010053.
61. Martins, M., McCusker, M. P., Viveiros, M., Couto, I., Fanning, S., Pagès, J. M., et al. (2013b). A simple method for assessment of MDR bacteria for over-expressed efflux pumps. Open Microbiol. J. 7, 72-82. doi: 10.2174/1874285801307010072.
62. Martins, A., Iversen, C., Rodrigues, L., Spengler, G., Ramos, J., Kern, W. V., et al. (2009a). An AcrAB-mediated multidrug-resistant phenotype is maintained following restoration of wild-type activities by efflux pump genes and their regulators. Int. J. Antimicrob. Agents 34, 602-604. doi: 10.1016/j.ijantimicag.2009.06.029.
63. Martins, A., Spengler, G., Rodrigues, L., Viveiros, M., Ramos, J., Martins, M., et al. (2009b). pH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colon. PLoS ONE 4:e6656. doi: 10.1371/journal.pone.0006656.
64. Martins, M., Viveiros, M., Couto, I., and Amaral, L. (2009c). Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB. Int. J. Tuberc. Lung Dis. 13, 569-573.
65. Martins, A., Machado, L., Costa, S., Cerca, P., Spengler, G., Viveiros, M., et al. (2011a). Role of calcium in the efflux system of Escherichia coli. Int. J. Antimicrob. Agents 37, 410-414. doi: 10.1016/j.ijantimicag.2011.01.010.
66. Martins, M., Viveiros, M., Couto, I., Costa, S. S., Pacheco, T., Fanning, S., et al. (2011b). Identification of efflux pump-mediated multidrug-resistant bacteria by the ethidium bromide-agar cartwheel method. In Vivo 25, 171-178.
67. Martins, A., Spengler, G., Molnar, J., and Amaral, L. (2012). Sequential responses of bacteria to noxious agents (antibiotics) leading to accumulation of mutations and permanent resistance. Biochem. Pharmacol. J. Open Access 1, 7.
68. Martins, M., Bleiss, W., Marko, A., Ordway, D., Viveiros, M., Leandro, C., et al. (2004). Clinical concentrations of thioridazine enhance the killing of intracellular methicillin-resistant Staphylococcus aureus: an in vivo, ex vivo and electron microscopy study. In Vivo 18, 787-794.
69. Martins, M., Couto, I., Viveiros, M., and Amaral, L. (2010). Identification of efflux-mediated multi-drug resistance in bacterial clinical isolates by two simple methods. Methods Mol. Biol. 642, 143-157. doi: 10.1007/978-1-60327-279-7_11.
70. Moitra, K., Silverton, L., Limpert, K., Im, K., and Dean, M. (2011). Moving out: from sterol transport to drug resistance-the ABCG subfamily of efflux pumps. Drug Metab. Drug Interact. 26, 105-111. doi: 10.1515/DMDI.2011.015.
71. Motohashi, N., Kawase, M., Molnár, J., Ferenczy, L., Wesolowska, O., Hendrich, A. B., et al. (2003). Antimicrobial activity of N-acylphenothiazines and their influence on lipid model membranes and erythrocyte membranes. Arzneimittelforschung 53, 590-599. doi: 10.1055/s-0031-1297154.
72. Mulkidjanian, A. Y. (2006). Proton in the well and through the desolvation barrier. Biochim. Biophys. Acta 1757, 415-427. doi: 10.1016/j.bbabio.2006.04.023.
73. Mulkidjanian, A. Y., Cherepanov, D. A., Heberle, J., and Junge, W. (2005). Proton transfer dynamics at membrane/water interface and mechanism of biological energy conversion. Biochemistry (Mosc.) 70, 251-256. doi: 10.1007/s10541-005-0108-1.
74. Mulkidjanian, A. Y., Heberle, J., and Cherepanov, D. A. (2006). Protons @ interfaces: implications for biological energy conversion. Biochim. Biophys. Acta 1757, 913-930. doi: 10.1016/j.bbabio.2006.02.015.
75. Nakajima, H., Kobayashi, K., Kobayashi, M., Asako, H., and Aono, R. (1995). Overexpression of the robA gene increases organic solvent tolerance and multiple antibiotic and heavy metal ion resistance in Escherichia coli. Appl. Environ. Microbiol. 61, 2302-2307.
76. Nikaido, H. (2001). Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin. Cell Dev. Biol. 12, 215-223. doi: 10.1006/scdb.2000.0247.
77. Nikaido, H. (2003). Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67, 593-656. doi: 10.1128/MMBR.67.4.593-656.2003.
78. Nikaido, H. (2011). Structure and mechanism of RND-type multidrug efflux pumps. Adv. Enzymol. Relat. Areas Mol. Biol. 77, 1-60.
79. Okusu, H., Ma, D., and Nikaido, H. (1996). AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J. Bacteriol. 178, 306-308.
80. Ordway, D., Viveiros, M., Leandro, C., Bettencourt, R., Almeida, J., Martins, M., et al. (2003). Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47, 917-922. doi: 10.1128/AAC.47.3.917-922.2003.
81. Padan, E., Bibi, E., Ito, M., and Krulwich, T. A. (2005). Alkaline pH homeostasis in bacteria: new insights. Biochim. Biophys. Acta 1717, 67-88. doi: 10.1016/j.bbamem.2005.09.010.
82. Pagès, J. M., and Amaral, L. (2009). Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim. Biophys. Acta 1794, 826-833. doi: 10.1016/j.bbapap.2008.12.011.
83. Pagès, J. M., Amaral, L., and Fanning, S. (2011). An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat Gram-negative resistant bacteria. Curr. Med. Chem. 18, 2969-2980. doi: 10.2174/092986711796150469.
84. Pagès, J. M., James, C. E., and Winterhalter, M. (2008). The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat. Rev. Microbiol. 6, 893-903. doi: 10.1038/nrmicro1994.
85. Pages, J. M., Masi, M., and Barbe, J. (2005). Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol. Med. 11, 382-389. doi: 10.1016/j.molmed.2005.06.006.
86. Paixão, L., Rodrigues, L., Couto, I., Martins, M., Fernandes, P., de Carvalho, C. C., et al. (2009). Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. J. Biol. Eng. 3, 18. doi: 10.1186/1754-1611-3-18.
87. Piddock, L. J. (2006). Multidrug-resistance efflux pumps-not just for resistance. Nat. Rev. Microbiol. 4, 629-636. doi: 10.1038/nrmicro1464.
88. Pratt, L. A., and Silhavy, T. J. (1996). The response regulator SprE controls the stability of RpoS. Proc. Natl. Acad. Sci. U.S.A. 93, 2488-2492. doi: 10.1073/pnas.93.6.2488.
89. Prebble, J. N. (1996). Successful theory development in biology: a consideration of the theories of oxidative phosphorylation proposed by Davies and Krebs, Williams and Mitchell. Biosci. Rep. 16, 207-215. doi: 10.1007/BF01207335.
90. Randall, L. P., and Woodward, M. J. (2002). The multiple antibiotic resistance (mar) locus and its significance. Res. Vet. Sci. 72, 87-93. doi: 10.1053/rvsc.2001.0537.
91. Roberts, I. S. (1996). The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu. Rev. Microbiol. 50, 285-315. doi: 10.1146/annurev.micro.50.1.285.
92. Rodrigues, L., Machado, D., Couto, I., Amaral, L., and Viveiros, M. (2012). Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex. Infect. Genet. Evol. 12, 695-700. doi: 10.1016/j.meegid.2011.08.009.
93. Rodrigues, L., Sampaio, D., Couto, I., Machado, D., Kern, W. V., Amaral, L., et al. (2009). The role of efflux pumps in macrolide resistance in Mycobacterium avium complex. Int. J. Antimicrob. Agents 34, 529-533. doi: 10.1016/j.ijantimicag.2009.07.010.
94. Sanches, I. S., Ramirez, M., Troni, H., Abecassis, M., Padua, M., Tomasz, A., et al. (1995). Evidence for the geographic spread of a methicillin-resistant Staphylococcus aureus clone between Portugal and Spain. J. Clin. Microbiol. 33, 1243-1246.
95. Seeger, M. A., Diederichs, K., Eicher, T., Brandstätter, L., Schiefner, A., Verrey, F., et al. (2008). The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance. Curr. Drug Targets 9, 729-749. doi: 10.2174/138945008785747789.
96. Spengler, G., Evaristo, M., Handzlik, J., Serly, J., Molnár, J., Viveiros, M., et al. (2010). Biological activity of hydantoin derivatives on P-glycoprotein (ABCB1) of mouse lymphoma cells. Anticancer Res. 30, 4867-4871.
97. Spengler, G., Ramalhete, C., Martins, M., Martins, A., Serly, J., Viveiros, M., et al. (2009a). Evaluation of cucurbitane-type triterpenoids from Momordica balsamina on P-glycoprotein (ABCB1) by flow cytometry and real-time fluorometry. Anticancer Res. 29, 3989-3993.
98. Spengler, G., Viveiros, M., Martins, M., Rodrigues, L., Martins, A., Molnar, J., et al. (2009b). Demonstration of the activity of P-glycoprotein by a semi-automated fluorometric method. Anticancer Res. 29, 2173-2177.
99. Spengler, G., Rodrigues, L., Martins, M., McCusker, M., Cerca, P., Machado, L., et al. (2012). Genetic response of Salmonella enterica serovar Typhimurium to thioridazine rendering the organism resistant to the agent. Int. J. Antimicrobial. Agents 39, 16-21. doi: 10.1016/j.ijantimicag.2011.08.013.
100. Su, C. C., and Yu, E. W. (2007). Ligand-transporter interaction in the AcrB multidrug efflux pump determined by fluorescence polarization assay. FEBS Lett. 581, 4972-4976. doi: 10.1016/j.febslet.2007.09.035.
101. Szabó, M. A., Varga, G. Z., Hohmann, J., Schelz, Z., Szegedi, E., Amaral, L., et al. (2010). Inhibition of quorum-sensing signals by essential oils. Phytother. Res. 24, 782-786. doi: 10.1002/ptr.3010.
102. Takács, D., Cerca, P., Martins, A., Riedl, Z., Hajós, G., Molnár, J., et al. (2011). Evaluation of forty new phenothiazine derivatives for activity against intrinsic efflux pump systems of reference Escherichia coli, Salmonella Enteritidis, Enterococcus faecalis and Staphylococcus aureus strains. In Vivo 25, 719-724.
103. Varga, Z. G., Armada, A., Cerca, P., Amaral, L., Mior Ahmad Subki, M. A., Savka, M. A., et al. (2012). Inhibition of quorum sensing and efflux pump system by trifluoromethyl ketone proton pump inhibitors. In Vivo 26, 277-285.
104. Viveiros, M., Jesus, A., Brito, M., Leandro, C., Martins, M., Ordway, D., et al. (2005). Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and the expression of proton gradient dependent multidrug efflux pump genes. Antimicrob. Agents Chemother. 49, 3578-3582. doi: 10.1128/AAC.49.8.3578-3582.2005.
105. Viveiros, M., Martins, M., Couto, I., Rodrigues, L., Spengler, G., Martins, A., et al. (2008). New methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps. Curr. Drug Targets 9, 760-778. doi: 10.2174/138945008785747734.
106. Viveiros, M., Martins, M., Rodrigues, L., Machado, D., Couto, I., Ainsa, J., et al. (2012). Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs. Expert Rev. Antiinfect. Ther. 10, 983-998. doi: 10.1586/eri.12.89.
107. Viveiros, M., Rodrigues, L., Dupont, M., Martins, M., Couto, I., Pagès, J. M., et al. (2007). Antibiotic stress, genetic response and altered permeability of E. coli. PLoS ONE 2:e365. doi: 10.1371/journal.pone.0000365.
108. Viveiros, M., Rodrigues, L., Martins, M., Couto, I., Spengler, G., Martins, A., et al. (2010). Evaluation of efflux activity of bacteria by a semi-automated fluorometric system. Methods Mol. Biol. 642, 159-172. doi: 10.1007/978-1-60327-279-7_12.
109. Walker, J. E., Saraste, M., and Gay, N. J. (1984). The unc operon. Nucleotide sequence, regulation and structure of ATP-synthase. Biochim. Biophys. Acta 768, 164-200. doi: 10.1016/0304-4173(84)90003-X.